Improving Medication Adherence with a Pharmacist-­Led MTM Clinic in the Primary Care Setting

Objective. The purpose of this study is to assess medication adherence and HEDIS STAR Ratings in patients using ACE inhibitor/ARB, statins and/or anti-diabetic medications through pharmacist-led Medication Therapy Management (MTM) in an accountable care organization. Background. Previous studies show improved clinical outcomes through MTM due to improved medication adherence. Additionally, literature demonstrates that involving pharmacists further improves outcomes due to their expertise and capability to properly counsel patients on their medications. HEDIS STAR Measures is a tool used to measure adherence and it ranges from 1-5 stars (lowest to highest). Methods. In this retrospective cohort study, data were collected via chart review of pharmacist-led MTM patient interviews and follow-ups between October 2015 and April 2017. Eligible patients for this study must be at least 18 years of age and have at least one chronic disease state, for which they take ACE inhibitor/ARB, statin or diabetic medication. Results. A total of 118 patients were referred to MTM clinic, which resulted in a total of 115 interventions (1:1 ratio of intervention to patient). Out of the 118 patients, 36 had a follow-up visit, resulting in 47 interventions (1.3:1). Prior to MTM clinic, most STAR ratings were 3. Post-MTM clinic, most ratings were 4’s or 5’s across all medication categories. Conclusion. Having a pharmacist-led MTM clinic in the primary care setting helps improve medication adherence and HEDIS STAR ratings in patients with chronic conditions. Funding. Non